Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric R Braverman

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
The American Journal of Medicine|July 26, 2016
From Leptin, DEXA, and BeyondEric R Braverman
Clinical EEG (Electroencephalography)|October 3, 2003
P300 (latency) event-related potential: an accurate predictor of memory impairmentEric R Braverman, Kenneth Blum
Plos One|April 10, 2012
Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptinNirav R Shah, Eric R Braverman
Medical Hypotheses|October 19, 2004
From brain science to brain based medicineEric R Braverman, Ken Blum, Matthew Stanford
Postgraduate Medicine|January 8, 2014
Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?Mark S Gold, Kenneth Blum, Marlene Oscar-Berman, et al.
BMC Research Notes|February 25, 2014
"Cold" X5 Hairlaser™ used to treat male androgenic alopecia and hair growth: an uncontrolled pilot studyKenneth Blum, David Han, Margaret A Madigan, et al.
Psychology (Irvine, Calif.)|July 11, 2014
Hypothesizing Darkness Induced Alcohol Intake Linked to Dopaminergic Regulation of Brain FunctionKenneth Blum, Marlene Oscar-Berman, Rajendra Badgaiyan, et al.
Global Journal of Addiction & Rehabilitation Medicine|February 6, 2018
Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD)Kenneth Blum, Margaret A Madigan, Lyle Fried, et al.
Journal of Reward Deficiency Syndrome|August 26, 2015
Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-RewardKenneth Blum, Marlene Oscar-Berman, Eric R Braverman, et al.
Plos One|March 26, 2013
Evoked potentials and neuropsychological tests validate Positron Emission Topography (PET) brain metabolism in cognitively impaired patientsEric R Braverman, Kenneth Blum, Uma J Damle, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
The American Journal of Medicine|July 26, 2016
From Leptin, DEXA, and BeyondEric R Braverman
Clinical EEG (Electroencephalography)|October 3, 2003
P300 (latency) event-related potential: an accurate predictor of memory impairmentEric R Braverman, Kenneth Blum
Plos One|April 10, 2012
Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptinNirav R Shah, Eric R Braverman
Medical Hypotheses|October 19, 2004
From brain science to brain based medicineEric R Braverman, Ken Blum, Matthew Stanford
Postgraduate Medicine|January 8, 2014
Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?Mark S Gold, Kenneth Blum, Marlene Oscar-Berman, et al.
BMC Research Notes|February 25, 2014
"Cold" X5 Hairlaser™ used to treat male androgenic alopecia and hair growth: an uncontrolled pilot studyKenneth Blum, David Han, Margaret A Madigan, et al.
Psychology (Irvine, Calif.)|July 11, 2014
Hypothesizing Darkness Induced Alcohol Intake Linked to Dopaminergic Regulation of Brain FunctionKenneth Blum, Marlene Oscar-Berman, Rajendra Badgaiyan, et al.
Global Journal of Addiction & Rehabilitation Medicine|February 6, 2018
Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD)Kenneth Blum, Margaret A Madigan, Lyle Fried, et al.
Journal of Reward Deficiency Syndrome|August 26, 2015
Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-RewardKenneth Blum, Marlene Oscar-Berman, Eric R Braverman, et al.
Plos One|March 26, 2013
Evoked potentials and neuropsychological tests validate Positron Emission Topography (PET) brain metabolism in cognitively impaired patientsEric R Braverman, Kenneth Blum, Uma J Damle, et al.
Pageof 11